Smoking cessation drug has fewer side effects than initially believed
A commonly prescribed drug to aid in smoking cessation does not cause cardiac symptoms or depression, as previously believed. This according to a study of 150,000 smokers who used the medication to help them quit smoking. A team of researchers from Maastricht UMC+ and the universities of Dusseldorf, Edinburg and London researched the alleged side effects of the drug varenicline. Their research findings were published in the leading scientific journal The Lancet Respiratory Medicine.
Many people find it difficult to quit smoking due to the addictive properties of nicotine. The presence of this substance in cigarette smoke causes an intense and constant craving for a cigarette. Quitting suddenly has been linked to withdrawal symptoms, such as depression, insomnia, difficulty concentrating and restlessness. Certain medications can help people quit smoking. Varenicline, which mimics the effects of nicotine, is one of the most common and the most effective drugs. However, it was also believed to have potential side effects like depression and cardiac symptoms. According to the latest study, these claims are unfounded.
Safe and effective
The researchers compared data on 150,000 smokers who wanted to quit with the help of smoking cessation aids like nicotine gum, nicotine patches or varenicline. They researched the health effects of these treatments over a period of six months and found that varenicline did not increase the risk of cardiac arrest or depression compared to the other treatment options. 'The results prove that this is a safe drug to help people quit smoking,' says head researcher Professor Daniel Kotz, who is affiliated with the universities of Dusseldorf and Maastricht.
Withdrawal
'If you've been smoking for years and suddenly stop, this will naturally have an effect on your body,' says co-author Professor Onno van Schayck of Maastricht UMC+. 'Depression and cardiac symptoms are potential consequences of long-term smoking. This means they are not caused by medication and that drugs can be safely prescribed as a tool to help people quit smoking. It's important that people who plan to quit are aware of the effects this can have on their body and mind in the short and the long term.'
Also read
-
Guangzhi Tang, Assistant Professor, Faculty of Science and Engineering, Department of Advanced Computing Sciences van de Universiteit Maastricht receives a grant for his project Brain-inspired MatMul-free Deep Learning for Sustainable AI on Neuromorphic
-
The research institutes M4I and MERLN, both part of Maastricht University (UM), are to become partners in a new national collaboration as of 1 January 2025. The Nijmegen-based laser and magnet lab HFML-FELIX will become an NWO Institute under the umbrella of the Foundation for Dutch Scientific Research Institutes (NWO-I) from that date. The two Maastricht institutes will act as official partners in this unique, large-scale scientific infrastructure in the Netherlands. In addition to NWO, Radboud University and UM, five other universities are involved in this special partnership.
-
This semester, the Green Office cultivated the untapped potential of the Community Garden and the Clothing Swap Room. We hope that these Circularity Projects will operate under autonomous, functional organisations by this time next year, with continued support from the Green Office and the SUM2030 team.
